FSGS

This study tests a drug called atacicept in 200 adults and teens with several autoimmune kidney diseases, including IgA nephropathy and focal segmental glomerulosclerosis. The goal is to see if it safely reduces protein in the urine and helps preserve kidney function. Participant…

This study tests a new drug, DMX-200, for people with a rare kidney disease called FSGS. The drug aims to reduce protein in the urine and protect kidney function. About 286 adults and teens will take DMX-200 or a placebo for up to 2 years, with an option to continue treatment for…

This study gathers information and biological samples from 300 people with FSGS or MCD who have had or will have a kidney transplant. Researchers want to learn why these kidney diseases sometimes come back after transplant and how to improve treatment. Participants provide data o…

This study helps people with nephrotic syndrome and related kidney diseases find clinical trials that may be a good fit for their specific condition. Researchers use detailed molecular information from each participant to recommend targeted therapies being tested in other studies…

This early-stage study is testing a new oral drug called SK-09 in 72 healthy adults to see if it is safe and how the body processes it. The trial is the first time SK-09 is given to humans, and it does not aim to treat any disease yet. Results will help decide if further studies …

This study interviews 150 children, adults, and parents about their experiences with swelling caused by Nephrotic Syndrome. Researchers will use the information to create a survey that helps test new medications. No treatment is given; the goal is to better understand symptoms.